Department of Endocrinology, Xiangya-Shenzhen Endocrinology and Metabolism Center, the First Affiliated Hospital of Shenzhen University, Shenzhen, People's Republic of China.
Genomic and Environmental Medicine Section, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London, SW3 6LY, UK.
BMC Endocr Disord. 2019 Aug 27;19(1):88. doi: 10.1186/s12902-019-0419-7.
Glycosylated hemoglobin (HbA1c) has a detrimental impact on the myocardium with left ventricular (LV) diastolic dysfunction. Obesity is a risk factor of type 2 diabetes. To understand the relationships between HbA1c, body mass index (BMI) and LV diastolic dysfunction, we performed this interaction analysis in patients with type 2 diabetes.
Total 925 type 2 diabetes patients were selected from the patients who were diagnosed and treated at the First Affiliated Hospital of Shenzhen University. Patients' BMI levels were defined as normal (BMI < 24 kg/m) and overweight /obese (BMI ≥ 24 kg/m). Patients' HbA1c levels were grouped as HbA1c ≥ 9%、7% ≤ HbA1c < 9% and HbA1c < 7%. Logistic regression, stratified, interaction analysis, multivariate Cox regression and curve fitting analysis were performed to investigate the correlations and interactions between HbA1c and BMI with LV diastolic dysfunction.
The BMI levels were significantly associated with LV diastolic dysfunction in the patients with type 2 diabetes [adjusted model: 1.12 (1.05, 1.20), P = 0.001]. While HbA1c levels had association with LV diastolic dysfunction only in normal BMI group patients [adjusted model: 1.14 (1.01, 1.30), P = 0.0394] and curve correlation was observed. There was a significant interaction between BMI and HbA1c to affect LV diastolic dysfunction (P = 0.0335). Cox regression model analysis showed that the risk of LV diastolic dysfunction was a U type correlation with HbA1c levels in the normal weight group and the turning point was HbA1c at 10%. HbA1c level was not found to have a significant association with LV diastolic dysfunction in overweight/obese group.
In patients with type 2 diabetes, correlation between LV diastolic dysfunction and HbA1c was interactively affected by BMI. Glycemic control is beneficial to the heart function in normal body weight patients. For overweight/obese patients, the risk of LV diastolic dysfunction was not determined by the HbA1c level, indicating it may be affected by other confounding factors.
糖化血红蛋白(HbA1c)对左心室(LV)舒张功能障碍的心肌有不良影响。肥胖是 2 型糖尿病的一个危险因素。为了了解 HbA1c、体重指数(BMI)与 LV 舒张功能障碍之间的关系,我们在 2 型糖尿病患者中进行了这项交互分析。
从在深圳大学第一附属医院诊断和治疗的患者中选择了 925 名 2 型糖尿病患者。患者的 BMI 水平定义为正常(BMI<24kg/m)和超重/肥胖(BMI≥24kg/m)。将患者的 HbA1c 水平分为 HbA1c≥9%、7%≤HbA1c<9%和 HbA1c<7%。采用 logistic 回归、分层、交互分析、多变量 Cox 回归和曲线拟合分析来研究 HbA1c 和 BMI 与 LV 舒张功能障碍之间的相关性和交互作用。
在 2 型糖尿病患者中,BMI 水平与 LV 舒张功能障碍显著相关[调整模型:1.12(1.05,1.20),P=0.001]。而 HbA1c 水平仅与正常 BMI 组患者的 LV 舒张功能障碍相关[调整模型:1.14(1.01,1.30),P=0.0394],并观察到曲线相关性。BMI 和 HbA1c 之间存在显著的交互作用,影响 LV 舒张功能障碍(P=0.0335)。Cox 回归模型分析表明,在正常体重组中,LV 舒张功能障碍的风险与 HbA1c 水平呈 U 型相关,转折点为 10%的 HbA1c。在超重/肥胖组中,未发现 HbA1c 水平与 LV 舒张功能障碍有显著相关性。
在 2 型糖尿病患者中,LV 舒张功能障碍与 HbA1c 之间的相关性受 BMI 交互影响。血糖控制对正常体重患者的心脏功能有益。对于超重/肥胖患者,LV 舒张功能障碍的风险不是由 HbA1c 水平决定的,这表明可能受到其他混杂因素的影响。